Targeted Antibiotics for Lower Respiratory Tract Infection with Corynebacterium striatum

References

• Zasada A, Mosiej A. Contemporary microbiology and identification of Corynebacteria Corynebacteria spp. causing infections in human. Lett Appl Microbiol. 2018;66(6):472–483. doi:10.1111/lam.12883
   PubMed Web of Science ®Google Scholar
• Milosavljevic MN, Milosavljevic JZ, Kocovic AG, et al. Antimicrobial treatment of Corynebacterium striatum invasive infections: a systematic review. Rev Inst Med Trop Sao Paulo. 2021;18(63):e49. doi:10.1590/s1678-9946202163049
   Google Scholar
• Alibi S, Ferjani A, Boukadida J, et al. Occurrence of Corynebacterium striatum as an emerging antibiotic-resistant nosocomial pathogen in a Tunisian hospital. Sci Rep. 2017;7(1):9704. doi:10.1038/s41598-017-10081-y
   PubMed Web of Science ®Google Scholar
• Wang X, Zhou H, Chen D, et al. Whole-genome sequencing reveals a prolonged and persistent intrahospital transmission of Corynebacterium striatum, an emerging multidrug-resistant pathogen. J Clin Microbiol. 2019;57(9):e00683–19. doi:10.1128/JCM.00683-19
   PubMedGoogle Scholar
• Silva-Santana G, Silva CMF, Olivella JGB, et al. Worldwide survey of Corynebacterium striatum increasingly associated with human invasive infections, nosocomial outbreak, and antimicrobial multidrug-resistance, 1976–2020. Arch Microbiol. 2021;203(5):1863–1880. doi:10.1007/s00203-021-02246-1
   PubMed Web of Science ®Google Scholar
• Chen H, Bai X, Gao Y, Liu W, Yao X, Wang J. Profile of bacteria with ARGs among real-world samples from ICU admission patients with pulmonary infection revealed by metagenomic NGS. Infect Drug Resist. 2021;27(14):4993–5004. doi:10.2147/IDR.S335864
   Google Scholar
• Renom F, Gomila M, Garau M, et al. Respiratory infection by Corynebacterium striatum: epidemiological and clinical determinants. New Microbes New Infect. 2014;2(4):106–114. doi:10.1002/nmi2.48
   PubMedGoogle Scholar
• Shariff M, Aditi A, Beri K. Corynebacterium striatum: an emerging respiratory pathogen. J Infect Dev Ctries. 2018;12(7):581–586. doi:10.3855/jidc.10406
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. doi:10.1097/00003246-198510000-00009
   PubMed Web of Science ®Google Scholar
• Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet. 2006;368(9530):157–169. doi:10.1016/S0140-6736(06)69005-3
   PubMed Web of Science ®Google Scholar
• Raith EP, Udy AA, Bailey M, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317(3):290–300. doi:10.1001/jama.2016.20328
   PubMed Web of Science ®Google Scholar
• Reifeis SA, Hudgens MG. On variance of the treatment effect in the treated when estimated by inverse probability weighting. Am J Epidemiol. 2022;191(6):1092–1097. doi:10.1093/aje/kwac014
   PubMedGoogle Scholar
• Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Stürmer T. Variable selection for propensity score models. Am J Epidemiol. 2006;163(12):1149–1156. doi:10.1093/aje/kwj149
   PubMed Web of Science ®Google Scholar
• Kazuhiro Y, Hiroshi M. Corynebacterium species as one of the major causative pathogens of bacterial pneumonia. Respir Investig. 2020;58(3):131–133. doi:10.1016/j.resinv.2020.01.008
   PubMedGoogle Scholar
• Chapartegui-González I, Fernández-Martínez M, Rodríguez-Fernández A, et al. Antimicrobial susceptibility and characterization of resistance mechanisms of Corynebacterium urealyticum clinical isolates. Antibiotics. 2020;9(7):404. doi:10.3390/antibiotics9070404
   Google Scholar
• Xw A, Hz A, Pd B, et al. Genomic epidemiology of Corynebacterium striatum from three regions of China: an emerging national nosocomial epidemic. J Hosp Infect. 2021;110:67–75. doi:10.1016/j.jhin.2020.10.005
   PubMed Web of Science ®Google Scholar
• Campanile F, Carretto E, Barbarini D, et al. Clonal multidrug-resistant Corynebacterium striatum strains, Italy. Emerg Infect Dis. 2009;15(1):75–78. doi:10.3201/eid1501.080804
   PubMedGoogle Scholar
• Verroken A, Bauraing C, Deplano A, et al. Epidemiological investigation of a nosocomial outbreak of multidrug‐resistant Corynebacterium striatum at one Belgian university hospital. Clin Microbiol Infect. 2014;20(1):44–50. doi:10.1111/1469-0691.12197
   PubMed Web of Science ®Google Scholar
• Asgin N, Otlu B. Antimicrobial resistance and molecular epidemiology of Corynebacterium striatum isolated in a Tertiary Hospital in Turkey. Pathogens. 2020;9(2):136. doi:10.3390/pathogens9020136
   PubMed Web of Science ®Google Scholar
• Suh JW, Yongguk J, Lee CK, Sohn JW, Kim MJ, Yoon YK. Molecular epidemiology and clinical significance of Corynebacterium striatum isolated from clinical specimens. Infect Drug Resist. 2019;12:161–171. doi:10.2147/IDR.S184518
   PubMed Web of Science ®Google Scholar
• Hahn WO, Werth BJ, Butler-Wu SM, Rakita RM. Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs. Emerg Infect Dis. 2016;22(11):1908–1914. doi:10.3201/eid2211.160141
   PubMed Web of Science ®Google Scholar
• Russell CD, Parajuli A, Gale HJ, et al. The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: a systematic review and meta-analysis. J Infect. 2019;78(5):339–348. doi:10.1016/j.jinf.2019.02.006
   PubMed Web of Science ®Google Scholar
• Jeffres MN. The whole price of vancomycin: toxicities, troughs, and time. Drugs. 2017;77(11):1143–1154. doi:10.1007/s40265-017-0764-7
   PubMed Web of Science ®Google Scholar
• Von Drygalski A, Curtis BR, Bougie DW, et al. Vancomycin-Induced Immune Thrombocytopenia. N Engl J Med. 2007;356(9):904–910. doi:10.1056/NEJMoa065066
   PubMed Web of Science ®Google Scholar